Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up

By Lam J.S.   Romas N.A.   Lowe F.C.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 354-358

Elsevier

Access to resources Recommend Favorite

Effects of finasteride and cyproterone acetate on hematuria associated with benign prostatic hyperplasia: a prospective, randomized, controlled study

By Perimenis P.   Gyftopoulos K.   Markou S.   Barbalias G.  

Urology, Vol. 59, Iss. 3, 2002-03 ,pp. : 373-377

Elsevier

Access to resources Recommend Favorite

Long-term treatment with doxazosin in men with benign prostatic hyperplasia: 10-year follow-up

By Dutkiewicz Sławomir  

International Urology and Nephrology, Vol. 36, Iss. 2, 2004-06 ,pp. : 169-173

Springer Publishing Company

Access to resources Recommend Favorite

Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia

By Lowe F.C.   McConnell J.D.   Hudson P.B.   Romas N.A.   Boake R.   Lieber M.   Elhilali M.   Geller J.   Imperto-McGinely J.   Andriole G.L.   Bruskewitz R.C.   Walsh P.C.   Bartsch G.   Nacey J.N.   Shah S.   Pappas F.   Ko A.   Cook T.   Stoner E.   Waldstreicher J.   FINASTERIDE STUDY GROUP  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 791-796

Elsevier

Access to resources Recommend Favorite

Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia

By Vaughan D.   Imperato-McGinley J.   McConnell J.   Matsumoto A.M.   Bracken B.   Roy J.   Sullivan M.   Pappas F.   Cook T.   Daurio C.   Meehan A.   Stoner E.   Waldstreicher J.  

Urology, Vol. 60, Iss. 6, 2002-12 ,pp. : 1040-1044

Elsevier

Access to resources Recommend Favorite